Weight loss now tops diabetes as primary use for GLP-1 drugs

More people now use GLP-1 drugs for weight loss than to manage diabetes. Industry trade publication Grocery Dive reports that data firm Numerator’s latest quarterly GLP-1 tracker finds that 22% of households now have a current GLP-1 user, more than twice as many as in October 2023. GLP-1 users are also spending nearly 4% less at the grocery store and more on self-care and wellness items. Another survey, by data firm Kantar, finds that 79% of users across the globe take the drugs for weight loss, while 58% use them for managing diabetes. Kantar notes that “GLP-1s are not a pharmaceutical trend, but a behavior-shifting platform” that has implications for brand and retailers.